SELENIUM SULFIDE and ALOPECIA

Overview

ALOPECIA is the #5 most commonly reported adverse reaction for SELENIUM SULFIDE, manufactured by Chattem, Inc.. There are 40 FDA adverse event reports linking SELENIUM SULFIDE to ALOPECIA. This represents approximately 2.6% of all 1,547 adverse event reports for this drug.

Patients taking SELENIUM SULFIDE who experience alopecia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

ALOPECIA is a less commonly reported adverse event for SELENIUM SULFIDE, but still significant enough to appear in the safety profile.

Other Side Effects of SELENIUM SULFIDE

In addition to alopecia, the following adverse reactions have been reported for SELENIUM SULFIDE:

• DRUG INEFFECTIVE — 123 reports
• PRURITUS — 61 reports
• HAIR COLOUR CHANGES — 55 reports
• NO ADVERSE EVENT — 51 reports
• PAIN — 38 reports
• CONDITION AGGRAVATED — 35 reports
• HAIR TEXTURE ABNORMAL — 31 reports
• NAUSEA — 31 reports
• PRODUCT ODOUR ABNORMAL — 30 reports
• FATIGUE — 29 reports

Other Drugs Associated with ALOPECIA

The following drugs have also been linked to alopecia in FDA adverse event reports:

Does SELENIUM SULFIDE cause ALOPECIA?

ALOPECIA has been reported as an adverse event in 40 FDA reports for SELENIUM SULFIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is ALOPECIA with SELENIUM SULFIDE?

ALOPECIA accounts for approximately 2.6% of all adverse event reports for SELENIUM SULFIDE, making it a notable side effect.

What should I do if I experience ALOPECIA while taking SELENIUM SULFIDE?

If you experience alopecia while taking SELENIUM SULFIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages